Home › Funds › Two Sigma Investments › ANRO
Two Sigma Investments position in ANRO
ALTO NEUROSCIENCE INC · Health Care
Latest position (Q2 2026)147.30K sh
Reported value held$3.89M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 12.94K | $148.03K | New |
| Q4 2024 | 30.70K | $129.86K | Add |
| Q1 2025 | 26.14K | $56.47K | Reduce |
| Q2 2025 | 44.73K | $98.42K | Add |
| Q3 2025 | 116.58K | $468.65K | Add |
| Q4 2025 | 140.32K | $2.50M | Add |
| Q1 2026 | 216.10K | $4.86M | Add |
| Q2 2026 | 147.30K | $3.89M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ANRO
- BlackRock Inc 2.12M sh · $55.97M · Q2 2026
- Franklin Resources 1.01M sh · $26.74M · Q2 2026
- Vanguard Group 1.37M sh · $24.31M · Q4 2025
- Geode Capital Management 678.20K sh · $17.90M · Q2 2026
- Northern Trust Corp 632.70K sh · $16.70M · Q2 2026
- Millennium Management 558.32K sh · $14.73M · Q2 2026
- Point72 Asset Management 502.95K sh · $13.27M · Q2 2026
- Goldman Sachs Group 236.83K sh · $6.25M · Q2 2026
- Marshall Wace 225.50K sh · $5.95M · Q2 2026
- Alkeon Capital Management 102.10K sh · $2.69M · Q2 2026
- Charles Schwab Investment Management 80.58K sh · $2.13M · Q2 2026